Clinical Trials Sponsored by Banner Alzheimer's Institute

Total 20739 results

Barnes Retina Institute

Unknown

Intraocular Pressure Accuracy and Variability of the Barraquer Tonometer

Elevated Intraocular Pressure

United States
Kentuckiana Cancer Institute

Completed

Iscar for Second Line Treatment of Advanced Non-Small Cell Lung Cancer

Non-Small Cell Lung Cancer

United States
Dana-Farber Cancer Institute
National Cancer Institute (NCI)

Recruiting

Insomnia Prevention in Children With Acute Lymphoblastic Leukemia

Leukemia | Acute Lymphoblastic Leukemia | Pediatric Acute Lymphoblastic Leukemia

United States
Roswell Park Cancer Institute
National Cancer Institute (NCI)

Recruiting

Behavioral Parenting Skills As A Novel Target for Improving Pediatric Medication Adherence

Acute Lymphoblastic Leukemia

United States
Dana-Farber Cancer Institute
National Cancer Institute (NCI)

Recruiting

Sleep Treatment Education Program-1 (STEP-1)

Insomnia | Cancer Survivors

United States
Dana-Farber Cancer Institute
National Cancer Institute (NCI)

Recruiting

Taking AIM at Breast Cancer

Breast Cancer | Breast Cancer Stage I | Breast Cancer Stage II | Breast Cancer Stage III

United States
Roswell Park Cancer Institute
National Cancer Institute (NCI)

Recruiting

Pharmacokinetics, Subjective Effects, and Abuse Liability of Nicotine Salt-Based Vaping Products With Tobacco or Unflavored E-liquids, SALTVAPE Study

Nicotine Dependence

United States
Roswell Park Cancer Institute
National Cancer Institute (NCI)

Recruiting

Porfimer Sodium Interstitial Photodynamic Therapy With or Without Standard of Care Chemotherapy in Treating Patients With Locally Advanced or Recurrent Head and Neck Cancer

Recurrent Head and Neck Carcinoma | Locally Advanced Head and Neck Carcinoma

United States
Roswell Park Cancer Institute
National Cancer Institute (NCI)

Active, not recruiting

Genetically Modified T Cells and Decitabine in Treating Patients With Recurrent or Refractory Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

Recurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma

United States
Dana-Farber Cancer Institute
National Cancer Institute (NCI)

Active, not recruiting

Systematic Hereditary Pancreatic Cancer Risk Assessment and Implications for Personalized Therapy

Pancreatic Cancer

United States
Dana-Farber Cancer Institute
National Cancer Institute (NCI)

Active, not recruiting

Neoantigen Vaccine Plus Locally Administered Ipilimumab and Systemic Nivolumab in Advanced Melanoma

Melanoma

United States
Roswell Park Cancer Institute
National Cancer Institute (NCI)

Withdrawn

Specialized Immune Cells (nCTLs) and a Vaccine (Alpha-type-1 Polarized Dendritic Cells) in Treating Patients With Stage II-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Stage III Fallopian Tube Cancer AJCC v8 | Stage III Ovarian Cancer AJCC v8 | Stage III Primary Peritoneal Cancer AJCC v8 | Stage IIIA Fallopian Tube Cancer AJCC v8 | Stage IIIA Ovarian Cancer AJCC v8 | Stage IIIA Primary Peritoneal Cancer AJCC v8 | Stage IIIA1 Fallopian Tube Cancer AJCC v8 | Stage... and other conditions

United States
Dana-Farber Cancer Institute
National Cancer Institute (NCI)

Active, not recruiting

Physical Activity, Proliferation and Immune Markers in Benign Breast Tissue

Breast Cancer

United States
Dana-Farber Cancer Institute
National Cancer Institute (NCI)

Completed

BOLSTER: Building Out Lifelines for Safety, Trust, Empowerment and Renewal

Gynecologic Cancer | Gastrointestinal Cancer

United States
Dana-Farber Cancer Institute
National Cancer Institute (NCI)

Active, not recruiting

A Novel Intervention for Patients With Cancer

Cancer | Substance Use | Psychological

United States
Roswell Park Cancer Institute
National Cancer Institute (NCI)

Completed

Photodynamic Therapy Using HPPH in Treating Patients With Stage 0 Non-Small Cell Lung Cancer

Lung Cancer

United States
Roswell Park Cancer Institute
National Cancer Institute (NCI)

Withdrawn

A Cytomegalovirus-Directed Vaccine (CMV-alphaDC1) for Preventing Cytomegalovirus Infection or Reactivation in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

Hematopoietic and Lymphoid System Neoplasm | Cytomegaloviral Infection

United States
Dana-Farber Cancer Institute
National Cancer Institute (NCI)

Active, not recruiting

Positive Psychology Intervention In HSCT (PATH-3)

Hematopoietic/Lymphoid Cancer | Hematologic Malignancy | Blood Cancer

United States
Roswell Park Cancer Institute
National Cancer Institute (NCI)

Suspended

Rintatolimod and IFN Alpha-2b for the Treatment of COVID-19 in Cancer Patients

Hematopoietic and Lymphoid Cell Neoplasm | Malignant Solid Neoplasm | Symptomatic COVID-19 Infection Laboratory-Confirmed

United States
Roswell Park Cancer Institute
National Cancer Institute (NCI)

Completed

Problem Solving Skills Training in Adult Cancer Survivors: Bright IDEAS-AC

Colo-rectal Cancer

United States
OHSU Knight Cancer Institute
National Cancer Institute (NCI)

Completed

DSC-MRI With Ferumoxytol and DCE-MRI With Gadolinium in Imaging Vascular Properties in Younger Patients With Brain Tumors

Childhood Brain Neoplasm | Recurrent Childhood Brain Neoplasm

United States
Roswell Park Cancer Institute
National Cancer Institute (NCI)

Terminated

Photodynamic Therapy With HPPH Compared to Standard of Care Surgery in Treating Patients With Oral Cavity Cancer

Stage I Oral Cavity Squamous Cell Carcinoma | Stage II Oral Cavity Squamous Cell Carcinoma

United States
Roswell Park Cancer Institute
National Cancer Institute (NCI)

Terminated

Nintedanib Compared With Placebo in Treating Against Radiation-Induced Pneumonitis in Patients With Non-small Cell Lung Cancer That Cannot Be Removed by Surgery and Are Undergoing Chemoradiation Therapy

Lung Non-Squamous Non-Small Cell Carcinoma | Stage II Lung Non-Small Cell Cancer AJCC v7 | Stage IIA Lung Non-Small Cell Carcinoma AJCC v7 | Stage IIB Lung Non-Small Cell Carcinoma AJCC v7 | Stage IIIA Lung Non-Small Cell Cancer AJCC v7 | Stage IIIB Lung Non-Small Cell Cancer AJCC v7 | Stage IV... and other conditions

United States
Roswell Park Cancer Institute
National Cancer Institute (NCI)

Completed

Fludarabine Phosphate, Melphalan, Total-Body Irradiation, Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Bone Marrow Failure Disorders

Primary Myelofibrosis | Chronic Myelomonocytic Leukemia | Recurrent Adult Acute Myeloid Leukemia | Juvenile Myelomonocytic Leukemia | Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Adult Burkitt Lymphoma | Recurrent... and other conditions

United States
Dana-Farber Cancer Institute
National Cancer Institute (NCI)

Completed

Multiple Risk Behavior Intervention in Health Care Settings (HD2)

Health Behavior | Risk Reduction Behavior

United States
Dana-Farber Cancer Institute
National Cancer Institute (NCI)

Unknown

Naloxone in Treating Constipation in Patients Who Are Receiving Opioids for Chronic Pain

Unspecified Adult Solid Tumor, Protocol Specific | Constipation, Impaction, and Bowel Obstruction

United States
OHSU Knight Cancer Institute
National Cancer Institute (NCI)

Completed

Exercise and Nutrition Program in Improving Physical Activity and Dietary Behavior in Non-Active, Overweight, or Obese Latinas

Obesity | Overweight

United States
Roswell Park Cancer Institute
National Cancer Institute (NCI)

Completed

Calcitriol in Preventing Lung Cancer in Smokers and Former Smokers at High Risk of Lung Cancer

Tobacco Use Disorder | Lung Cancer | Precancerous Condition

United States
Roswell Park Cancer Institute
National Cancer Institute (NCI)

Withdrawn

Sirolimus and Vaccine Therapy in Treating Patients With Stage II-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Recurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Stage IIA Fallopian Tube Cancer | Stage IIA Ovarian Cancer | Stage IIB Fallopian Tube Cancer | Stage IIB Ovarian Cancer | Stage IIC Fallopian Tube Cancer | Stage IIC Ovarian Cancer | Stage IIIA Fallopian... and other conditions

United States
Dana-Farber Cancer Institute
National Cancer Institute (NCI)

Completed

Talotrexin in Treating Patients With Advanced or Recurrent Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific

United States
Roswell Park Cancer Institute
National Cancer Institute (NCI)

Terminated

Capecitabine, Oxaliplatin, Selenomethionine, and Radiation Therapy in Treating Patients Undergoing Surgery For Newly Diagnosed Stage II or III Rectal Adenocarcinoma

Colorectal Cancer

United States
Roswell Park Cancer Institute
National Cancer Institute (NCI)

Terminated

Interstitial Photodynamic Therapy in Treating Patients With Recurrent Head and Neck Cancer

Recurrent Laryngeal Squamous Cell Carcinoma | Recurrent Oropharyngeal Squamous Cell Carcinoma | Recurrent Lip and Oral Cavity Squamous Cell Carcinoma | Recurrent Laryngeal Verrucous Carcinoma | Recurrent Metastatic Squamous Cell Carcinoma in the Neck With Occult Primary | Recurrent Oral Cavity... and other conditions

United States
Roswell Park Cancer Institute
National Cancer Institute (NCI)

Completed

Pegfilgrastim and Rituximab in Treating Patients With Untreated, Relapsed, or Refractory Follicular Lymphoma, Small Lymphocytic Lymphoma, or Marginal Zone Lymphoma

Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Recurrent Grade 3 Follicular Lymphoma | Recurrent Marginal Zone Lymphoma | Splenic Marginal Zone... and other conditions

United States
OHSU Knight Cancer Institute
National Cancer Institute (NCI)

Terminated

Donor Stem Cell Transplant or Donor White Blood Cell Infusions in Treating Patients With Hematologic Cancer

Lymphoma | Myelodysplastic Syndromes | Leukemia | Chronic Myeloproliferative Disorders | Multiple Myeloma and Plasma Cell Neoplasm | Myelodysplastic/Myeloproliferative Neoplasms | Unusual Cancers of Childhood

United States
OHSU Knight Cancer Institute
National Cancer Institute (NCI)

Completed

Busulfan, Melphalan, and Thiotepa in Treating Patients Who Are Undergoing an Autologous Stem Cell Transplant for Hodgkin's or Non-Hodgkin's Lymphoma

Lymphoma

United States
OHSU Knight Cancer Institute
National Cancer Institute (NCI)

Terminated

Flu,Alemtuzumab,and TBI Followed By Donor Stem Cell Chronic Phase CML

Leukemia

United States
OHSU Knight Cancer Institute
National Cancer Institute (NCI)

Completed

Fluocinonide Cream in Treating Symptoms of Vaginal Dryness and Painful Sexual Intercourse In Patients With Breast Cancer Undergoing Hormone Therapy

Breast Carcinoma

United States
Dana-Farber Cancer Institute
National Cancer Institute (NCI)

Terminated

Vaccine Therapy in Treating Patients With Acute Lymphoblastic Leukemia

Leukemia

United States
OHSU Knight Cancer Institute
National Cancer Institute (NCI)

Terminated

Blood Samples From Patients on a Clinical Trial to CINV During HSCT

Lymphoma | Myelodysplastic Syndromes | Leukemia | Testicular Germ Cell Tumor | Breast Cancer | Chronic Myeloproliferative Disorders | Ovarian Cancer | Gestational Trophoblastic Tumor | Neuroblastoma | Multiple Myeloma and Plasma Cell Neoplasm | Myelodysplastic/Myeloproliferative Neoplasms | Nausea and Vomiting

United States
OHSU Knight Cancer Institute
National Cancer Institute (NCI)

Completed

Calcitriol, Mitoxantrone, and Prednisone in Treating Patients With Metastatic Prostate Cancer

Prostate Cancer

United States
OHSU Knight Cancer Institute
National Cancer Institute (NCI)

Completed

Calcitriol and Carboplatin in Treating Patients With Stage IV Prostate Cancer That Has Not Responded to Hormone Therapy

Prostate Cancer

United States
OHSU Knight Cancer Institute
National Cancer Institute (NCI)

Terminated

Paclitaxel Poliglumex and Estradiol in Treating Patients With Stage IV Prostate Cancer

Prostate Cancer

United States
Dana-Farber Cancer Institute
National Cancer Institute (NCI)

Completed

Hyperthermia Plus Radiation Therapy in Treating Patients With Nonmetastatic Advanced Prostate Cancer

Prostate Cancer

United States
OHSU Knight Cancer Institute
National Cancer Institute (NCI)

Completed

Methotrexate, Procarbazine, Lomustine, Dexamethasone, and Cytarabine in Treating Patients With Primary CNS Lymphoma (Protocol-A)

Lymphoma

United States
Dana-Farber Cancer Institute
National Cancer Institute (NCI)

Completed

Gene Therapy in Treating Patients With Unresectable, Recurrent, or Refractory Head and Neck Cancer

Head and Neck Cancer

United States
Dana-Farber Cancer Institute
National Cancer Institute (NCI)

Completed

Vaccine Therapy in Treating Patients With Metastatic Breast Cancer

Breast Cancer

United States
Dana-Farber Cancer Institute
National Cancer Institute (NCI)

Completed

Gemcitabine in Treating Patients With Advanced Salivary Gland Cancer That Cannot Be Removed During Surgery

Head and Neck Cancer

United States
Roswell Park Cancer Institute
National Cancer Institute (NCI)

Withdrawn

Pan FGFR Kinase Inhibitor BGJ398 and Combination Chemotherapy in Treating Patients With Untreated Metastatic Pancreatic Cancer

Pancreatic Adenocarcinoma | Stage IIIA Rectal Cancer | Stage IIIB Rectal Cancer | Stage IIIC Rectal Cancer | Pancreatic Ductal Adenocarcinoma | Metastatic Pancreatic Adenocarcinoma | Stage III Pancreatic Cancer | Stage IV Pancreatic Cancer | Rectal Adenocarcinoma | Stage IIIA Colon Cancer | Stage IIIB Colon... and other conditions

United States
Roswell Park Cancer Institute
National Cancer Institute (NCI)

Withdrawn

Photodynamic Therapy With HPPH in Treating Patients With Squamous Cell Carcinoma of the Oral Cavity

Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity | Recurrent Squamous Cell Carcinoma of the Oropharynx | Recurrent Verrucous Carcinoma of the Oral Cavity | Stage I Squamous Cell Carcinoma of the Lip and Oral Cavity | Stage I Squamous Cell Carcinoma of the Oropharynx | Stage I Verrucous... and other conditions

United States
OHSU Knight Cancer Institute
National Cancer Institute (NCI)

Completed

OX-40 Protein Expression in the Sentinel Lymph Nodes of Patients With Cancer

Cancer

United States

Clinical Trials Sponsored by Banner Alzheimer's Institute

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Estonia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations